第一作者单位:[1]Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai, Peoples R China
推荐引用方式(GB/T 7714):
Ni J.,Wu L.,Chu Q.,et al.Sintilimab, SBRT and GM-CSF for Metastatic NSCLC: A Prospective, Multicenter, Phase II Trial[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2023,117(2):E44-E44.
APA:
Ni, J.,Wu, L.,Chu, Q.,Han, C.,Ai, X....&Zhu, Z..(2023).Sintilimab, SBRT and GM-CSF for Metastatic NSCLC: A Prospective, Multicenter, Phase II Trial.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,117,(2)
MLA:
Ni, J.,et al."Sintilimab, SBRT and GM-CSF for Metastatic NSCLC: A Prospective, Multicenter, Phase II Trial".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 117..2(2023):E44-E44